AI English summary of an SEC filing — figures as filed
The Estée Lauder Companies ELThe company said reported skin care operating income decreased for 3 months ended December 31, 2023 and 6 months. The company cited lower net sales at Estée Lauder and higher obsolescence charges from excess inventory, driven by lower-than-expected demand in its travel retail business and mainland China.
Key points
AI summaryThe company said reported skin care operating income decreased for 3 months ended December 31, 2023 and 6 months. The company cited lower net sales at Estée Lauder and higher obsolescence charges from excess inventory, driven by lower-than-expected demand in its travel retail business and mainland China.
The company said The Americas operating results decreased for 6 months, and that intercompany royalty income was $270 million lower than the prior-year period, driven by lower net sales in its travel retail business. On a 3-month basis, the decline in intercompany royalty income was $85 million.
The company said Asia/Pacific operating income decreased over 6 months, with the combined decline in mainland China and Taiwan operating results totaling approximately $145 million. It said the year-over-year effect of the other intangible asset impairment related to Dr.Jart+ of $100 million recorded in Korea in Q2 was reflected in the region.
The company said cash and cash equivalents were $3,939 million as of December 31, 2023 and $4,029 million as of June 30, 2023. It said the ratio of debt to total capitalization was 59% at both dates.
Key figures
Quarter ended December 31, 2023
- Revenue
- $4.3B
- Operating income
- $574M
- Net income
- $324M
- EPS
- $0.87
- Gross profit
- $3.1B
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Skin Care Operating Income Decline and Inventory Obsolescence Charges
The company said reported skin care operating income decreased for 3 months ended December 31, 2023 and 6 months. The company cited lower net sales at Estée Lauder and higher obsolescence charges from excess inventory, driven by lower-than-expected demand in its travel retail business and mainland China.
Source · Based on the MD&A text of the filing
The Americas and Travel Retail Intercompany Royalty Changes
The company said The Americas operating results decreased for 6 months, and that intercompany royalty income was $270 million lower than the prior-year period, driven by lower net sales in its travel retail business. On a 3-month basis, the decline in intercompany royalty income was $85 million.
Source · Based on the MD&A text of the filing
Asia/Pacific Operating Income Change and Dr.Jart+ Impairment
The company said Asia/Pacific operating income decreased over 6 months, with the combined decline in mainland China and Taiwan operating results totaling approximately $145 million. It said the year-over-year effect of the other intangible asset impairment related to Dr.Jart+ of $100 million recorded in Korea in Q2 was reflected in the region.
Source · Based on the MD&A text of the filing
Cash Balance and Debt-to-Total-Capitalization Ratio
The company said cash and cash equivalents were $3,939 million as of December 31, 2023 and $4,029 million as of June 30, 2023. It said the ratio of debt to total capitalization was 59% at both dates.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…